v3.26.1
Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Jun. 30, 2024
Product Information [Line Items]                
Loss from operations $ 231,000 $ 228,000 $ 954,000 $ 753,000        
Net cash used in operating activities     527,000 624,000        
Accumulated deficit 467,000 (299,000) 467,000 (299,000) $ (69,000) $ 248,000 $ 23,000 $ 480,000
Cash in amount 45,000   45,000   249,000      
Revenues 3,000 122,000 6,000 198,000        
Advertising expenses     12,000 10,000        
Research and development costs $ 42,000 11,000 $ 66,000        
Accounts receivable $ 3,000   $ 3,000   $ 10,000      
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Desmet [Member]                
Product Information [Line Items]                
Concentration risk, percentage       100.00%        
Accounts Payable [Member] | Customer Concentration Risk [Member] | Vendor One [Member]                
Product Information [Line Items]                
Concentration risk, percentage     21.00%   68.00%      
Accounts Payable [Member] | Customer Concentration Risk [Member] | Vendor Two [Member]                
Product Information [Line Items]                
Concentration risk, percentage     20.00%   21.00%      
Accounts Payable [Member] | Customer Concentration Risk [Member] | Vendor Three [Member]                
Product Information [Line Items]                
Concentration risk, percentage     13.00%